Gerresheimer AG Logo

Gerresheimer AG

Global provider of packaging and drug delivery systems for pharma, biotech, and cosmetics.

GXI | F

Overview

Corporate Details

ISIN(s):
DE000A0LD6E6
LEI:
5299006GD4UWSYZOKC28
Country:
Germany
Address:
Klaus-Bungert-Straße 4, 40468 Düsseldorf
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Gerresheimer AG is a global partner and solutions provider specializing in primary packaging and drug delivery systems for the pharmaceutical, biotech, and cosmetics industries. The company develops and manufactures a broad portfolio of high-quality glass and plastic products, including pharmaceutical vials, syringes, ampoules, cartridges, and containers. It also offers integrated solutions for drug delivery devices, such as inhalers and auto-injectors, acting as a full-service partner from concept development to the finished product. Additionally, Gerresheimer provides packaging for the perfume and personal care sectors and serves as a supplier for diagnostic and medical device components.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-20 13:18
Board/Management Information
Gerresheimer AG: Change in the Supervisory Board
English 9.3 KB
2025-11-19 18:38
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-18 10:02
Environmental & Social Information
Gerresheimer: Science Based Targets Initiative confirms CO2e Reduction Targets
English 13.3 KB
2025-11-17 17:11
Declaration of Voting Results & Voting Rights Announcements
English 13.4 KB
2025-11-12 18:26
Declaration of Voting Results & Voting Rights Announcements
English 15.5 KB
2025-11-10 16:10
Declaration of Voting Results & Voting Rights Announcements
English 16.8 KB
2025-11-06 11:32
Declaration of Voting Results & Voting Rights Announcements
English 14.3 KB
2025-11-03 11:36
Declaration of Voting Results & Voting Rights Announcements
English 16.3 KB
2025-10-31 11:32
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-30 10:54
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB
2025-10-29 10:40
Declaration of Voting Results & Voting Rights Announcements
English 16.0 KB
2025-10-28 16:10
Board/Management Information
Gerresheimer: Uwe Rohrhoff takes over as interim CEO for Dietmar Siemssen
English 10.5 KB
2025-10-27 10:05
Declaration of Voting Results & Voting Rights Announcements
English 14.9 KB
2025-10-25 19:24
Legal Proceedings Report
Gerresheimer AG: Initial findings of an external independent investigation into…
English 7.9 KB
2025-10-23 21:12
Declaration of Voting Results & Voting Rights Announcements
English 19.7 KB

Automate Your Workflow. Get a real-time feed of all Gerresheimer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Gerresheimer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Gerresheimer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-13 Siemssen, Dietmar Board Buy None 74,994.10 EUR
2022-10-14 Siemssen, Dietmar Board Buy None 137,500.00 EUR
2022-10-14 Simon-Schröter, Dr Wolfram Other Buy None 2,958.00 EUR
2022-09-19 Abt, Andrea Supervisory board Buy None 25,075.00 EUR
2022-09-19 Empl, Andreas Board Buy None 1,820.00 EUR
2022-07-18 Siemssen, Dietmar Board Buy None 151,730.25 EUR
2021-07-14 Burkhardt, Dr. Lukas Board Buy None 181,357.60 EUR
2021-07-14 Siemssen, Dietmar Board Buy None 139,732.50 EUR

Peer Companies

BECTON DICKINSON & CO Logo
Develops medical supplies, devices & diagnostics for healthcare and life science researchers.
United States of America
BDX
BELLUSCURA PLC Logo
Develops portable oxygen concentrators for patients needing supplemental oxygen.
United Kingdom
BELL
BENO TNR, Inc. Logo
A diversified firm in biotech, wearable robotics, and eco-friendly building materials.
South Korea
206400
Beta Bionics, Inc. Logo
Develops an automated insulin delivery system to simplify management of type 1 diabetes.
United States of America
BBNX
BibbInstruments AB Logo
Develops electric endoscopic biopsy tools for accurate cancer diagnosis in GI, lung, and urology.
Sweden
BIBB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.
South Korea
489460
Biocartis Group NV Logo
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
Belgium
BCART
Biocorp Logo
Develops and manufactures connected drug delivery systems and medical devices for pharma.
France
ALCOR
BIODESIX INC Logo
Develops blood-based diagnostic tests for lung disease to guide personalized treatment decisions.
United States of America
BDSX
BIODYNE CO., LTD. Logo
Develops automated liquid-based cytology systems and reagents for cancer diagnostics.
South Korea
314930

Talk to a Data Expert

Have a question? We'll get back to you promptly.